메뉴 건너뛰기




Volumn 170, Issue 5, 2010, Pages 291-313

Isavuconazole: A comprehensive review of spectrum of activity of a new triazole

Author keywords

Antifungal; Fungicidal; Fungistatic; In vitro activity; In vivo studies; Isavuconazole

Indexed keywords

ANTIFUNGAL AGENT; ISAVUCONAZOLE; NITRILE; PYRIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

EID: 78049352249     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11046-010-9324-3     Document Type: Review
Times cited : (121)

References (62)
  • 1
    • 42049092525 scopus 로고    scopus 로고
    • In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1, 007 isolates of zygomycete, candida, aspergillus, fusarium, and scedosporium species
    • Guinea J, Pelaez T, Recio S, Torres-Narbona M, Bouza E. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1, 007 isolates of zygomycete, candida, aspergillus, fusarium, and scedosporium species. Antimicrob Agents Chemother. 2008; 52: 1396-400.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 1396-1400
    • Guinea, J.1    Pelaez, T.2    Recio, S.3    Torres-Narbona, M.4    Bouza, E.5
  • 2
    • 42049109270 scopus 로고    scopus 로고
    • In vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba
    • Illnait-Zaragozi MT, Martinez GF, Curfs-Breuker I, Fernandez CM, Boekhout T, Meis JF. In vitro activity of the new azole isavuconazole (BAL4815) compared with six other antifungal agents against 162 Cryptococcus neoformans isolates from Cuba. Antimicrob Agents Chemother. 2008; 52: 1580-2.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 1580-1582
    • Illnait-Zaragozi, M.T.1    Martinez, G.F.2    Curfs-Breuker, I.3    Fernandez, C.M.4    Boekhout, T.5    Meis, J.F.6
  • 3
    • 30344449770 scopus 로고    scopus 로고
    • In vitro activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug), against Aspergillus spp
    • Warn PA, Sharp A, Denning DW. In vitro activity of a new triazole BAL4815, the active component of BAL8557 (the water-soluble prodrug), against Aspergillus spp. J Antimicrob Chemother. 2006; 57: 135-8.
    • (2006) J Antimicrob Chemother , vol.57 , pp. 135-138
    • Warn, P.A.1    Sharp, A.2    Denning, D.W.3
  • 4
    • 34248379039 scopus 로고    scopus 로고
    • In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates
    • Seifert H, Aurbach U, Stefanik D, Cornely O. In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates. Antimicrob Agents Chemother. 2007; 51: 1818-21.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 1818-1821
    • Seifert, H.1    Aurbach, U.2    Stefanik, D.3    Cornely, O.4
  • 6
    • 17644440661 scopus 로고    scopus 로고
    • Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole
    • Ohwada J, Tsukazaki M, Hayase T, et al. Design, synthesis and antifungal activity of a novel water soluble prodrug of antifungal triazole. Bioorg Med Chem Lett. 2003; 13: 191-6.
    • (2003) Bioorg Med Chem Lett. , vol.13 , pp. 191-196
    • Ohwada, J.1    Tsukazaki, M.2    Hayase, T.3
  • 7
    • 41949128129 scopus 로고    scopus 로고
    • New and emerging treatments for fungal infections
    • Pasqualotto AC, Denning DW. New and emerging treatments for fungal infections. J Antimicrob Chemother. 2008; 61(Suppl 1): i19-30.
    • (2008) J Antimicrob Chemother , vol.61 , Issue.SUPPL. 1
    • Pasqualotto, A.C.1    Denning, D.W.2
  • 8
    • 33845356887 scopus 로고    scopus 로고
    • Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus
    • Warn PA, Sharp A, Mosquera J, et al. Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. J Antimicrob Chemother. 2006; 58: 1198-207.
    • (2006) J Antimicrob Chemother , vol.58 , pp. 1198-1207
    • Warn, P.A.1    Sharp, A.2    Mosquera, J.3
  • 18
  • 19
    • 65649120454 scopus 로고    scopus 로고
    • In vitro activity of Isavuconazole against Aspergillus species and zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing
    • Perkhofer S, Lechner V, Lass-Florl C. In vitro activity of Isavuconazole against Aspergillus species and zygomycetes according to the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother. 2009; 53: 1645-7.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 1645-1647
    • Perkhofer, S.1    Lechner, V.2    Lass-Florl, C.3
  • 20
    • 34250341823 scopus 로고    scopus 로고
    • A higher-level phylogenetic classification of the Fungi
    • Hibbett DS, Binder M, Bischoff JF, et al. A higher-level phylogenetic classification of the Fungi. Mycol Res. 2007; 111: 509-47.
    • (2007) Mycol Res , vol.111 , pp. 509-547
    • Hibbett, D.S.1    Binder, M.2    Bischoff, J.F.3
  • 22
    • 33644661057 scopus 로고    scopus 로고
    • Head-to-head comparison of the activities of currently available antifungal agents against 3, 378 Spanish clinical isolates of yeasts and filamentous fungi
    • Cuenca-Estrella M, Gomez-Lopez A, Mellado E, Buitrago MJ, Monzon A, Rodriguez-Tudela JL. Head-to-head comparison of the activities of currently available antifungal agents against 3, 378 Spanish clinical isolates of yeasts and filamentous fungi. Antimicrob Agents Chemother. 2006; 50: 917-21.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 917-921
    • Cuenca-Estrella, M.1    Gomez-Lopez, A.2    Mellado, E.3    Buitrago, M.J.4    Monzon, A.5    Rodriguez-Tudela, J.L.6
  • 23
    • 67449108546 scopus 로고    scopus 로고
    • Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi
    • Wiederhold NP, Lewis RE. Antifungal activity against Scedosporium species and novel assays to assess antifungal pharmacodynamics against filamentous fungi. Med Mycol. 2009; 47: 422-32.
    • (2009) Med Mycol. , vol.47 , pp. 422-432
    • Wiederhold, N.P.1    Lewis, R.E.2
  • 25
    • 33747622240 scopus 로고    scopus 로고
    • Antifungal activity of BAL4815, a novel azole against dermatophytes and emerging non-dermatophyte fungi including zygomycetes
    • New Orleans Poster M-1623
    • Ghannoum M, Isham N. Antifungal activity of BAL4815, a novel azole against dermatophytes and emerging non-dermatophyte fungi including zygomycetes. In: Programs and abstracts of the 45th annual ICAAC annual meeting. New Orleans 2005. Poster M-1623.
    • (2005) Programs and abstracts of the 45th annual ICAAC annual meeting
    • Ghannoum, M.1    Isham, N.2
  • 26
    • 58149197661 scopus 로고    scopus 로고
    • In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi
    • Gonzalez GM. In vitro activities of isavuconazole against opportunistic filamentous and dimorphic fungi. Med Mycol. 2009; 47: 71-6.
    • (2009) Med Mycol. , vol.47 , pp. 71-76
    • Gonzalez, G.M.1
  • 28
    • 0034944963 scopus 로고    scopus 로고
    • In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature
    • Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia. 2001; 150: 101-15.
    • (2001) Mycopathologia , vol.150 , pp. 101-115
    • Espinel-Ingroff, A.1    Boyle, K.2    Sheehan, D.J.3
  • 29
    • 67749102126 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect
    • Warn PA, Sharp A, Parmar A, Majithiya J, Denning DW, Hope WW. Pharmacokinetics and pharmacodynamics of a novel triazole, isavuconazole: mathematical modeling, importance of tissue concentrations, and impact of immune status on antifungal effect. Antimicrob Agents Chemother. 2009; 53: 3453-61.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 3453-3461
    • Warn, P.A.1    Sharp, A.2    Parmar, A.3    Majithiya, J.4    Denning, D.W.5    Hope, W.W.6
  • 30
    • 78049326478 scopus 로고    scopus 로고
    • In vitro post antibiotic effect of isavuconazole, voriconazole, and amphotericin B against a strain of C. albicans with concentration dependent pharmacokinetics in a murine model and susceptibility of strains from mouse kidneys post infection
    • Barcelona: Poster P-2177
    • Warn PA, Sharp A, Majithiya JB, Parmar A, Denning DW. In vitro post antibiotic effect of isavuconazole, voriconazole, and amphotericin B against a strain of C. albicans with concentration dependent pharmacokinetics in a murine model and susceptibility of strains from mouse kidneys post infection. In: Programs and abstracts of the 18th European congress of clinical microbiology and infectious diseases (ECCMID). Barcelona: 2008. Poster P-2177.
    • (2008) Programs and abstracts of the 18th European congress of clinical microbiology and infectious diseases (ECCMID)
    • Warn, P.A.1    Sharp, A.2    Majithiya, J.B.3    Parmar, A.4    Denning, D.W.5
  • 31
    • 29944441643 scopus 로고    scopus 로고
    • Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers
    • Schmitt-Hoffmann A, Roos B, Heep M, et al. Single-ascending-dose pharmacokinetics and safety of the novel broad-spectrum antifungal triazole BAL4815 after intravenous infusions (50, 100, and 200 milligrams) and oral administrations (100, 200, and 400 milligrams) of its prodrug, BAL8557, in healthy volunteers. Antimicrob Agents Chemother. 2006; 50: 279-85.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 279-285
    • Schmitt-Hoffmann, A.1    Roos, B.2    Heep, M.3
  • 32
    • 57649180452 scopus 로고    scopus 로고
    • Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei
    • Majithiya J, Sharp A, Parmar A, Denning DW, Warn PA. Efficacy of isavuconazole, voriconazole and fluconazole in temporarily neutropenic murine models of disseminated Candida tropicalis and Candida krusei. J Antimicrob Chemother. 2009; 63: 161-6.
    • (2009) J Antimicrob Chemother , vol.63 , pp. 161-166
    • Majithiya, J.1    Sharp, A.2    Parmar, A.3    Denning, D.W.4    Warn, P.A.5
  • 33
    • 78049342495 scopus 로고    scopus 로고
    • Dose response curves and dose fractionation studies with BAL8557 in a murine model of disseminated aspergillosis
    • San Francisco A-1120
    • Warn PA, Sharp A, Denning D. Dose response curves and dose fractionation studies with BAL8557 in a murine model of disseminated aspergillosis. In: Programs and abstracts of the 46th ICAAC meeting. San Francisco 2006. A-1120.
    • (2006) Programs and abstracts of the 46th ICAAC meeting
    • Warn, P.A.1    Sharp, A.2    Denning, D.3
  • 34
    • 78049333446 scopus 로고    scopus 로고
    • Dose response in neutropenic mice with disseminated infection of multiple strains of Aspergillus fumigatus with widely varying MIC and MFC values treated with isavuconazole
    • Munich P-1951
    • Warn PA, Sharp A, Denning DW. Dose response in neutropenic mice with disseminated infection of multiple strains of Aspergillus fumigatus with widely varying MIC and MFC values treated with isavuconazole. In: Programs and abstracts of the 17th ECCMID meeting. Munich 2008. P-1951.
    • (2008) Programs and abstracts of the 17th ECCMID meeting
    • Warn, P.A.1    Sharp, A.2    Denning, D.W.3
  • 35
    • 85046687649 scopus 로고    scopus 로고
    • Correlation of in vitro MIC and MFC against isavuconazole, voriconazole, and amphotericin B of Aspergillus with in vivo outcome in mice with disseminated Aspergillosis
    • Barcelona P1915
    • Majithiya JB, Sharp A, Parmar A, Denning DW, Warn PA. Correlation of in vitro MIC and MFC against isavuconazole, voriconazole, and amphotericin B of Aspergillus with in vivo outcome in mice with disseminated Aspergillosis. In: Programs and abstracts of the 18th ECCMID meeting. Barcelona 2008. P1915.
    • (2008) Programs and abstracts of the 18th ECCMID meeting
    • Majithiya, J.B.1    Sharp, A.2    Parmar, A.3    Denning, D.W.4    Warn, P.A.5
  • 43
    • 84874937332 scopus 로고    scopus 로고
    • Efficacy, safety, and tolerability of three different dosing regimens of BAL8557 vs fluconazole in a double-blind randomized, multicenter trial for ther treatment of esophageal candidiasis in immunocompromised adults
    • Washington., Abstracct LB2-32. American Society for Microbiology, Washington
    • Viljoen JJ, Mitha I, Heep M, et al. Efficacy, safety, and tolerability of three different dosing regimens of BAL8557 vs fluconazole in a double-blind randomized, multicenter trial for ther treatment of esophageal candidiasis in immunocompromised adults. In: Abstracts of the forty-fifth interscience conference on antimicrobial agents and chemotherapy. Washington 2005. Abstracct LB2-32. American Society for Microbiology, Washington.
    • (2005) Abstracts of the forty-fifth interscience conference on antimicrobial agents and chemotherapy
    • Viljoen, J.J.1    Mitha, I.2    Heep, M.3
  • 48
    • 38149113811 scopus 로고    scopus 로고
    • Candida nivariensis isolated from an Indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis
    • Wahyuningsih R, SahBandar IN, Theelen B, et al. Candida nivariensis isolated from an Indonesian human immunodeficiency virus-infected patient suffering from oropharyngeal candidiasis. J Clin Microbiol. 2008; 46: 388-91.
    • (2008) J Clin Microbiol , vol.46 , pp. 388-391
    • Wahyuningsih, R.1    Sahbandar, I.N.2    Theelen, B.3
  • 49
    • 66749159129 scopus 로고    scopus 로고
    • Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov
    • Taj-Aldeen SJ, Al-Ansari N, El Shafei S, et al. Molecular identification and susceptibility of Trichosporon species isolated from clinical specimens in Qatar: isolation of Trichosporon dohaense Taj-Aldeen, Meis & Boekhout sp. nov. J Clin Microbiol. 2009; 47: 1791-9.
    • (2009) J Clin Microbiol , vol.47 , pp. 1791-1799
    • Taj-Aldeen, S.J.1    Al-Ansari, N.2    El Shafei, S.3
  • 53
    • 68349106776 scopus 로고    scopus 로고
    • In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries
    • Verweij PE, Gonzalez GM, Wiedrhold NP, et al. In vitro antifungal activity of isavuconazole against 345 mucorales isolates collected at study centers in eight countries. J Chemother. 2009; 21: 272-81.
    • (2009) J Chemother , vol.21 , pp. 272-281
    • Verweij, P.E.1    Gonzalez, G.M.2    Wiedrhold, N.P.3
  • 59
    • 78049344547 scopus 로고    scopus 로고
    • Diflucan [package insert]. New York NR 2004
    • Diflucan [package insert]. New York NR 2004.
  • 60
    • 78049327552 scopus 로고    scopus 로고
    • Sporanox [package insert]. Titusville NJP 2004
    • Sporanox [package insert]. Titusville NJP 2004.
  • 61
    • 78049353010 scopus 로고    scopus 로고
    • Posaconazole [package insert]. Kenilworth NSC
    • Posaconazole [package insert]. Kenilworth NSC.
  • 62
    • 78049350605 scopus 로고    scopus 로고
    • Vfend package insert; Pfizer Inc. NY
    • Vfend package insert; Pfizer Inc. NY.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.